Evidence map›Paper›PMID 41573234›Full record

ArticleAdvanced functional materials2025

High-Resolution Characterization of Protein-Conjugated, mRNA-Loaded Lipid Nanoparticles by Analytical Ultracentrifugation.

Sophia Bird, Connor Smith, Nahal Habibi, Samantha Rivera, Saeed Mortezazadeh, Reece Martin, Benjamin M Geilich, Gilles Besin, Borries Demeler

Abstract read
In one paragraph

Article in Advanced functional materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sophia BirdDepartment of Chemistry and Biochemistry, University of Lethbridge, Lethbridge, AB T1K4M3, Canada.
Connor SmithOrbital Therapeutics, Cambridge, MA02142, USA.
Nahal HabibiOrbital Therapeutics, Cambridge, MA02142, USA.
Samantha RiveraOrbital Therapeutics, Cambridge, MA02142, USA.
Saeed MortezazadehDepartment of Chemistry and Biochemistry, University of Lethbridge, Lethbridge, AB T1K4M3, Canada.
Reece MartinDepartment of Chemistry and Biochemistry, University of Lethbridge, Lethbridge, AB T1K4M3, Canada.
Benjamin M GeilichOrbital Therapeutics, Cambridge, MA02142, USA.
Gilles BesinOrbital Therapeutics, Cambridge, MA02142, USA.
Borries DemelerDepartment of Chemistry and Biochemistry, University of Lethbridge, Lethbridge, AB T1K4M3, Canada.

Funding

Development of an UltraScan Meta-Scheduler for HPC Job SubmissionR01GM120600 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Emre H. Brookes, BORRIES DEMELER · 2016 to 2026
$3.6M
NIGMS NIH HHS R01 GM120600
6 · The paper itself

Abstract

The study describes a novel use for the Custom Grid (CG) algorithm in UltraScan targeting lipid nanoparticles (LNPs) with cargos ranging from empty LNPs, LNPs loaded with messenger RNA (mRNA), and LNPs conjugated with proteins, or both. The CG method is used to fit sedimentation velocity analytical ultracentrifugation experiments performed in density matching mode to derive partial specific volume, molar mass, and hydrodynamic radius distributions for LNPs. Because LNP cargos often differ in density from the encapsulating lipids, density (or partial specific volume) is a critical quality attribute to quantify LNP composition and cargo loading. It is shown that the CG approach, in combination with D

Indexed as

analytical ultracentrifugationcustom gridlipid nanoparticle analysissedimentation velocityUltraScan

Identifiers

PMID41573234
PMCPMC12823152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.